The acute effect of in vitro deendothelialization on the production of prostacyclin (PG12) by the rabbit aorta has been investigated. The effectiveness of removing endothelium by rubbing it against filter paper or scraping it with a scalpel was demonstrated by scanning electron microscopy and en face examination after silver staining. Endothelium removal produced an immediate stimulation of PGI2 release, resulting in 408% of the control after rubbing and 367% of the control after scraping, during the first 30-min period of incubation. This increased production of PG12 gradually declined over time to reach values similar to the control after 2 h. At that time, the deendothelialized aorta was totally unresponsive to the stimuli that increase PG12 release in the intact aorta (acetylcholine, ADP, ionophore A23187, and arachidonic acid). The enhanced production of PG12 in the deendothelialized aorta was associated with an increased release of free arachidonic acid (353% of the control): in contrast with PG12, this stimulation was maintained for at least 150 min. A transient exposure of the deendothelialized aorta to ibuprofen (250 1M) was followed by a rebound of PG12 production, which was also prolonged by BW-755C (3-10 ;&M). In conclusion, removal of the endothelium triggered an immediate and sustained mobilization of free arachidonic acid in the rabbit aorta: the resulting increase of P012 production was short-lived, probably as a consequence of cyclooxygenase self-inactivation. Our results indicate that the subendothelium has a significant capacity to produce PGI2, but that this capacity is expressed only briefly.
Introduction
The relative contribution of the endothelium and the subendothelium to the production of prostacyclin (PGI2)' by arteries remains a controversial matter. PGI2 is the major eicosanoid produced by cultured smooth muscle cells from rat (1) , rabbit (2, 3) , and bovine (4-6) aorta, whereas smooth muscle cells from porcine aorta synthesize mainly prostaglandins E2 (PGE2) Fl,; PGE2, prostaglandin E2; PGF2,., prostaglandin F2l,; PG12, prostacyclin; RPHPLC, reversed-phase high performance liquid chromatography.
endothelium inhibits the capacity of dog femoral arteries to convert exogenous arachidonic acid into PGO2 ( 1) . Immunoradiometric assays and immunofluorescence studies have shown that the concentrations of PG12 synthase are equal in endothelial and smooth muscle cells of bovine aorta, but that the concentration of cyclooxygenase is 20-fold higher in the endothelial than in the smooth muscle cells (12, 13) . We have performed a detailed kinetic study of the consequences of in vitro deendothelialization on arachidonic acid release and PGO2 production in the rabbit aorta. Our results indicate that removal of the endothelium induces a sustained mobilization of free arachidonic acid and a transient stimulation of PG12 release: the subendothelium has a significant capacity to produce PG12, but, due to cyclooxygenase self-inactivation, the expression of this capacity is short-lived.
Methods
Preparation and incubation ofaortic strips. White male rabbits weighing -3 kg were killed by a blow on the neck. The aorta was quickly dissected from the iliac bifurcation up to the arch, trimmed free of fat and connective tissue, and cut into rings (±3 mm large). These rings were opened by a longitudinal incision, and the intimal face of some of the resulting strips was either rubbed for 30 s against filter paper or scraped with a scalpel. Immediately thereafter, the strips were incubated at 370C, under constant shaking (80 rpm), in a medium of the following composition: 124 mM NaCl; 5 mM KCI; 1.25 mM MgSO4;
1.45 mM CaCl2; 1.25 mM KH2PO4; 25 mM Hepes buffer, pH 7.4; and 8 mM glucose. The ratio of tissue weight to medium volume was roughly 25 mg/2 ml. In general the strips were incubated for five 30- min periods (60 min in some experiments), and the medium was replaced at the end of each period. For the measurement of arachidonic acid release, the same medium was used, but it contained in addition indomethacin (I gg/ml) and bovine serum albumin (BSA; 1 mg/ml).
In some experiments, the strips of rabbit aorta were placed between two plexiglass plates held together by two lateral screws. The upper plate, the base of which was constituted by the aortic luminal surface, contained six holes (5 mm) that served as incubation chambers. The chambers were filled with 300-,1 incubation medium and incubated at 37°C for six 30-min periods. At the end of each period, the incubation medium was collected and replaced. Within an experiment (performed with one aorta), each experimental condition was tested in duplicate or triplicate.
Prostaglandin radioimmunoassay (RIA). The production of PG12 was measured by the RIA of prostaglandin-6-keto-F,a (6-K-PGF,.), performed directly in the incubation medium without extraction and chromatography. A rabbit antiserum was raised against 6-K-PGF1,.
coupled to BSA, as described (14) : the limit of detection was 16 pg and the cross-reactions were 1.2% with PGF2., 0.3% with PGE2, and <0.1% with thromboxane B2. 20-or 50-Ml aliquots of incubation media, 3H-6-K-PGF,. (1 1,000 dpm), anti-6-K-PGF1,, antiserum (final dilution, l0-4), and bovine gamma globulins (0.25%) in Tris buffer (50 mM, pH 7.4) were incubated in a total volume of 0.4 ml for 60 min at room temperature. Then 0.4 ml of a cold 25% (wt/wt) solution of polyethylene glycol was added to separate bound and free antigen.
PGE2 was assayed by a similar method.
Metabolism of exogenous arachidonic acid. Intact and rubbed strips of rabbit aorta (±50 mg) were incubated for four 30-min periods, in 2 ml of the usual medium.
[3H]Arachidonic acid (135 Ci/mmol), purified shortly before use, was added at the beginning of the fourth period (I MCi/ml, 0.25 ug/ml). A 1.5-ml aliquot of the incubation medium was directly analyzed by reversed-phase high performance liquid chromatography (RPHPLC), using a g-Bondapak Ci8 column (3.9 X 300 min, 10 
Results
The endothelium was completely removed from the rabbit aorta strips after their luminal surfaces were rubbed against filter paper or scraped with a scalpel. The en face examination of the complete surfaces of numerous scraped strips, after silver staining, revealed the homogenous loss of the mosaic pattern characteristic of the endothelium (16) . Scanning electron microscopy provided similar results. Endothelium removal induced a transient increase of 6-K-PGFia release from the rabbit aorta strips (Fig. 1) . The amounts of 6-K-PGF1, (nanograms per 100 milligrams of tissue) released by the strips during the first 30-min incubation period after their preparation were for the intact, rubbed, and scraped strips, respectively, 67±8 (n = 23), 248±26 (n = 14), and 219±19 (n = 23) (mean±SE; n, number of experiments). Rubbing and scraping produced an equal stimulation of 6-K-PGFIa output of 408% of the respective controls in the case of rubbing and 367% in the case of scraping. To confirm that the product formed after endothelium removal was authentic 6-K-PGFia, RIA was repeated after RPHPLC purification of several samples. All the immunoreactivity was indeed recovered in the fractions where a standard of 6-K-PGFIa was eluted (data not shown). Scraping the endothelium of the dog aorta also stimulated the release of 6-K-PGFIa (270% of the control, mean of three experiments). The increased production of 6-K-PGFIa in the deendothelialized aorta progressively declined with time, both when the strips were incubated continuously in the same medium ( Fig. 1 ) and when the medium was changed every 30 min (Fig. 4) . Indomethacin abolished the release of 6-K-PGFIa induced by deendothelialization (Fig. 2) . Endothelium removal also increased the release of PGE2 by rabbit aorta strips but in smaller amounts (32 ng/100 mg during the first 30 min, or nine times less than the corresponding amounts of 6-K-PGFIa; mean of four experiments). PGE2 output decreased with time parallel to 6-K-PGFIat (data not shown). At the end of each period, the medium was collected and replaced. At the end of the third period, the intimal surface of all the strips was scraped with a scalpel before the incubation was resumed. Results represent the mean±SD of six determinations in two separate experiments.
Previous experiments had shown that rubbing the luminal surface abolished the stimulatory effects of acetylcholine (19) and ADP or ATP (20) on PGI2 production by the rabbit aorta. As shown on Figs. 3 and 4, the responses to ionophore A23 187 and arachidonic acid were also lost in strips of deendothelialized aorta obtained either by rubbing or by scraping. The 30-fold stimulation of 6-K-PGFia output by ionophore A23187 (5 MM) in the intact rabbit aorta was reduced to 1.3-fold in deendothelialized strips (mean of eight experiments). Continuous exposure of intact strips to arachidonic acid produced an increase of 6-K-PGFIa output, which was maximal at the beginning and progressively declined. The deendothelialized aorta was unresponsive to arachidonic acid from the start to the end of the incubation (Fig. 4) . Intact strips of rabbit aorta converted exogenous [3H]arachidonic acid mainly into 6-KPGFIa, and to a smaller extent into PGE2, PGF2a, and a compound coeluting with 12-hydroxyeicosatetraenoic acid (Fig.   5 ). Deendothelialized strips of aorta failed to metabolize exogenous arachidonic acid, although, as expected, they released larger amounts of endogenous 6-K-PGFIa than the intact ones (Fig. 5) . When only half of the luminal surface of the aorta strips was scraped, the initial stimulation of 6-K-PGFIa release was equal to that in completely denuded strips, whereas the response to ionophore A23 187 was partially maintained, roughly in proportion to the amount of residual endothelium (38% of the response in intact strips, mean of three experiments) (data not shown). The template procedure (10) was used to determine the effect of endothelium removal specifically on the release of PGI2 at the luminal surface of the aorta. As shown on Fig. 6 , deendothelialization increased the luminal release of 6-K-PGFIa and abolished the responsiveness to ionophore A23187.
Endothelium removal from the rabbit aorta induced the mobilization of free arachidonic acid, measured by its release into the albumin-containing incubation medium (Fig. 7) . Arachidonate release (nanomoles per 100 mg and per 30 min) was maximal during the first incubation period: 6.1±2.1 in scraped aorta strips compared with 1.7±0.5 in the intact ones (mean±SD; five experiments). During the next 90 min, arachidonic acid was mobilized at a lower rate, which was 3.5-fold higher in the scraped strips than in the intact ones (P = 0.04). This rate of release did not decrease significantly during this period (P = 0.12). Ionophore A23187 increased the release of free arachidonic acid in the intact aorta. This effect was lost after endothelium removal (Fig. 7) .
Further experiments were performed to explain the discrepancy between the progressive decline of 6-K-PGFa output (Figs. I and 4 ) and the continuous release of arachidonic acid (Fig. 7) release of 6-K-PGFIa from scraped aorta strips but had almost no effect on the intact aorta (Fig. 8) of prostaglandin synthase and that inactivate the cyclooxygenase (21) . BW-755C prolonged the release of 6-K-PGFIa by the deendothelialized rabbit aorta (Fig. 10) . 3 AM of BW-755C caused a negligible inhibition of 6-K-PGFI output during its 60-min exposure to the scraped aorta strips, followed by a doubling of 6-K-PGF1, release during the 90 min after the removal of the drug. 10 AM of BW-755C produced a 34% inhibition followed by a 2.7-fold stimulation. This stimulatory effect of BW-755C was highly significant (P = 0.002). Other antioxidants reported to protect the synthesis of PGI2, ascorbic acid (22) , and nafazatrom (23) did not modify the kinetics of 6-K-PGF1, release from the deendothelialized aorta (data not shown). ized rabbit aorta by exogenous PGH2 synthase. Aortic strips, intact (-) or deendothelialized (o) by scraping with a scalpel, were incubated for five 30-min periods. The incubation medium was replaced at the end of each period. At the start of the last period, PGH2 synthase (12.5 or 37.5 U/ml) and arachidonic acid (20:4, 2 ug/ml) were added as indicated. In the experiments depicted in B, all the strips were deendothelialized, and the concentration of PGH2 synthase was 12.5 U/ml. Negligible amounts of material reactive with the anti-6-K-PGFIa antibody were generated during an incubation of PGH2 synthase with arachidonic acid, in the absence of tissue. Results represent the mean±SD of six determinations in three separate experiments (A) and six determinations in two separate experiments (B).
Discussion
Our results indicate that the removal of the aortic endothelium induced a sustained mobilization of free arachidonic acid, a transient stimulation of PGI2 synthesis, and an increased release of PGI2 at the luminal surface, accompanied and followed by a complete unresponsiveness to all the stimuli that increase PGI2 in the intact aorta, including arachidonic acid itself. Since we checked carefully to see that the endothelium was completely removed by the mechanical procedures used, it is most likely that the events measured in this study occurred in the smooth muscle cells. Increased PGI2 synthesis
Prostacyclin Production by the Deendothelialized Rabbit Aorta 11 after endothelium removal is likely to be the consequence of the increased availability of free arachidonic acid. This spontaneous mobilization of endogenous arachidonic acid could also explain the lack of stimulatory effect of exogenous arachidonic acid on P012 production (saturation of the cyclooxygenase) and the inability of ionophore A23187 to release additional free arachidonic acid. The Whether smooth muscle cells contribute significantly to the production of PG12 by arteries remains a controversial issue. Studies performed with cultured aortic smooth muscle cells have not provided conclusive answers. PGI2 is the major eicosanoid produced by cells from rat, rabbit, and bovine aorta (1-6), whereas PGE2 and PGF2a are the main products formed in cells cultured from porcine aorta (7) (8) (9) . Aortic smooth muscle cells dedifferentiate in culture and lose some of their native properties, such as contractility (24) . Our observation that, after complete removal of the endothelium, the aorta was able to produce large amounts of P012, but less than the intact aorta stimulated by arachidonic acid and only for a short period (Fig. 4) (Fig. 5) , but the simultaneous measurement of the endogenous production of 6-K-PGFIa leads us to an opposite conclusion. The deendothelialized aorta released more PG12 than the intact one, and the lack of conversion of exogenous radiolabeled arachidonic acid may be the consequence of isotopic dilution by the large amounts of endogenous free arachidonic acid mobilized after endothelium removal. This underscores the danger of using the conversion of exogenous arachidonic acid as the only method to evaluate eicosanoid biosynthetic capacity. This is true also for the work of Eldor et al. (10) who have shown that removal of the endothelium from the rabbit aorta in vivo abolishes the conversion of exogenous arachidonic acid into PGI2 measured at the luminal surface. These authors did not report an increase of the spontaneous release of PGI2 after endothelium removal. Since the stimulation observed in our study was transient, it might have been missed in the time interval between the deendothelialization performed in vivo and the start of the in vitro incubation.
The short-lived release of PGI2, in spite of a continuous mobilization of endogenous free arachidonic acid, that we have observed in the deendothelialized rabbit aorta is similar to the transient production of PGI2 by the intact rabbit aorta continuously perfused with exogenous arachidonic acid (27) and to the observation that cultured endothelial cells respond to arachidonic acid only once (6, 28) . In each case, the rapid decline of PG12 production is likely to be due to self-inactivation of the cyclooxygenase, involving the irreversible oxidation of the enzyme by a free radical generated during the reduction of prostaglandin G2 into prostaglandin H2 (21, 27, 28) . Our results suggest that BW-755C, which, depending on the concentration, stimulates or inhibits cyclooxygenase in a cell-free preparation (21) , constitutes the model of a specific drug protecting against this inactivation in vascular smooth muscle cells. Indeed a concentration of BW-755C as low as 3 oM prolongs the release of PGI2 by the deendothelialized aorta.
Mechanical removal of the endothelium seems to represent a straightforward method to evaluate its contribution to phenomena occurring in arteries. In particular, this procedure has been used to demonstrate that acetylcholine and other agents relax the rabbit aorta and other arteries by acting on endothelial cells (29, 30) . Our study indicates that experiments involving endothelium removal should be interpreted with great caution, since this procedure dramatically alters the metabolism of arachidonic acid in the subendothelial layer. Other acute biochemical modifications after endothelium removal have been noticed in the aorta, including increased cyclic GMP content (31) and phosphorylation of one specific protein (32).
One question raised by our observations is whether the mobilization of arachidonic acid and the resulting PGI2 synthesis after endothelium removal is a mere consequence of the trauma imposed to the aortic smooth muscle or is due to the disruption of endothelial-smooth muscle cell interactions. Control and deendothelialized samples were submitted to the same trauma when the aorta was cut into rings. This trauma, followed by recovery, might be responsible for the initial and transient phase of free arachidonic acid release. It could be speculated that the sustained release observed in the deendothelialized aorta results from the permanent loss of some endothelium-smooth muscle interaction, of which several examples have been described (33) (34) (35) (36) , but additional studies are required to support this hypothesis. Whatever the mechanism involved, our study suggests that the local release of PGI2 induced by endothelial lesions might contribute to the increased systemic production of PGI2 observed in patients with atherosclerosis (37).
